Results 71 to 80 of about 21,846 (223)

Mast Cells in Host Defense Against Cutaneous Staphylococcus aureus Infection

open access: yesImmunology &Cell Biology, EarlyView.
Impact of S. aureus epicutaneous sensitization models on mast cell function in vivo. D. farinae and Staphylococcal enterotoxin B (SEB) activate Trpv1+ Tac1+ nociceptors to trigger the release of substance P (SP), which promotes mast cell degranulation through Mrgprb2. S.
Hannah Dychtenberg   +3 more
wiley   +1 more source

Ticlopidine Induced Bullous Pemphigoid [PDF]

open access: yes, 2009
Bullous pemphigoid (BP) is an acquired autoimmune disease that`s characterized by subepidermal vesicles and bullae. The etiology for BP is mostly idiopathic, but numerous observations have suggested the role of certain drugs in the occurrence of bullous ...
김수찬
core  

Clinical features and practical diagnosis of bullous pemphigoid

open access: yes, 2011
Bullous pemphigoid (BP) represents the most common autoimmune subepidermal blistering disease. BP typically affects the elderly and is associated with significant morbidity. It has usually a chronic course with spontaneous exacerbations.
della Torre, R   +8 more
core   +1 more source

Emerging Roles of PSTPIP2 in Autoimmunity: From Mechanism to Therapeutic Implications

open access: yesImmunology, EarlyView.
PSTPIP2 acts as a key brake on myeloid inflammation by suppressing IL‐1β‐driven signalling, macrophage dysregulation and inflammation‐associated bone remodelling. Its emerging roles in CRMO/CMO, rheumatoid arthritis, SAPHO syndrome and bullous pemphigoid support its potential as a biomarker and therapeutic target.
Erdong Zhang   +9 more
wiley   +1 more source

Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis

open access: yes, 2011
Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease of the skin associated with IgG autoantibodies to BP180 and BP230, while mucous membrane pemphigoid (MMP) comprises a heterogeneous group of autoimmune blistering diseases ...
Beltraminelli, H   +13 more
core   +1 more source

Management of Non‐Plaque‐Induced Gingival Conditions: A Systematic Review—Part 2: Inflammatory and Immune Conditions; Neoplasms; and Gingival Pigmentation

open access: yesJournal of Clinical Periodontology, EarlyView.
ABSTRACT Aims This systematic review assesses current evidence on the management of non‐plaque (dental biofilm)‐induced gingival diseases and conditions (NPIGDs), including (i) inflammatory and immune conditions, (ii) neoplasms and (iii) gingival pigmentations.
Maria Clotilde Carra   +5 more
wiley   +1 more source

Lymphotoxin detected in the blister fluid of bullous pemphigoid patients [PDF]

open access: yes, 1984
The role of lymphocytes in the pathogenesis of bullous pemphigoid was examined by assaying the blister fluid obtained from bullous pemphigoid patients for the presence of the lymphokine, lymphotoxin.
Edward W. B. Jeffes   +7 more
core   +1 more source

PUVA-induced Bullous Pemphigoid in Psoriasis [PDF]

open access: yes, 2016
The association between psoriasis vulgaris and bullous pemphigoid is due to the still unclear autoimmune process. The common place of action is dermo-epidermal junction or basal membrane zone (BMZ) with specific alterations for both diseases ...
V'lckova Laskoska, Marija   +5 more
core   +1 more source

Identification of Risk Factors for Gliptin-associated Bullous Pemphigoid among Diabetic Patients

open access: yesActa Dermato-Venereologica
Drug-associated bullous pemphigoid has been shown to follow long-term gliptin (dipeptidyl-peptidase 4 inhibitors) intake. This study aimed at identifying risk factors for gliptin-associated bullous pemphigoid among patients with type 2 diabetes.
Dana Shalmon   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy